Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
The three-year trial used immunoassays and PCR testing, and found 335 Babesia microti positive samples among 89,153 blood donations.
Roche's PCR-based Cobas test is also being deployed at one blood center in the US and is proving to be highly accurate, the agency said.
The Cobas Zika test is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus in plasma specimens from human blood donors.
The new Kansas City-based center will provide national genomic profiling of blood donations to more precisely match donors and transplant recipients, and reduce adverse outcomes.
The study showed that introducing a synthetic molecule into the blood of mice could force cancer cells, but not normal cells, to express a detectable biomarker.
The real-time PCR assay is designed to detect and identify HIV, hepatitis B virus, and hepatitis C virus in donations of human whole blood and blood components.
NEW YORK (GenomeWeb) — Hologic reported after the close of the market on Wednesday a 6 percent increase in revenues for its fiscal fourth quarter, including a 2 percent uptick in revenues for its Diagnostics business.
NEW YORK (GenomeWeb) — Roche said today that it has received CE marking for the cobas 6800/8800 automated molecular testing systems for blood and plasma donor screening.
NEW YORK (GenomeWeb News) — Grifols said today that it has been selected by the Japanese Red Cross Society as a partner in nucleic acid screening of the country's 5.3 million annual blood donations.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.